SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,322 | -67.6% | 621,317 | +110.5% | 0.03% | -69.3% |
| Q2 2023 | $352,766 | +27.9% | 295,202 | -26.0% | 0.10% | +17.4% |
| Q1 2023 | $275,881 | +8.9% | 399,133 | +7.0% | 0.09% | +21.1% |
| Q4 2022 | $253,323 | -47.7% | 373,083 | -20.6% | 0.07% | -45.8% |
| Q3 2022 | $484,000 | +95.2% | 470,151 | +29.0% | 0.13% | +89.9% |
| Q2 2022 | $248,000 | -17.6% | 364,597 | +1.6% | 0.07% | +38.0% |
| Q1 2022 | $301,000 | -6.2% | 358,796 | +82.4% | 0.05% | +28.2% |
| Q4 2021 | $321,000 | +156.8% | 196,677 | +280.0% | 0.04% | +95.0% |
| Q3 2021 | $125,000 | – | 51,760 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,908,725 | $5,056,000 | 0.66% |
| Uniplan Investment Counsel, Inc. | 2,485,327 | $2,559,000 | 0.20% |
| Oasis Management Co Ltd. | 850,000 | $876,000 | 0.15% |
| AdvisorShares Investments LLC | 470,151 | $484,000 | 0.13% |
| 1492 Capital Management LLC | 99,819 | $103,000 | 0.07% |
| Sovereign Financial Group, Inc. | 75,000 | $77,000 | 0.03% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 45,500 | $47,000 | 0.03% |
| MAI Capital Management | 1,230,810 | $1,268,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 137,266 | $141,000 | 0.02% |
| FORTEM FINANCIAL GROUP, LLC | 20,000 | $21,000 | 0.02% |